Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cencora (COR – Research Report) and Inari ...
Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.